Skip to main content

Table 2 Adjusted Prevalence Ratios and 95% confidence intervals (CI) for factors associated with the reporting of COVID-19 symptoms, testing and receiving a positive result, older adults, Brazil (July–November)

From: Coresidence increases the risk of testing positive for COVID-19 among older Brazilians

 

Symptoms

Testing

Positive

PR

95% CI

PR

95% CI

PR

95% CI

Fixed

 Living arrangement (versus older adult alone)

  Older adults only

0.726***

(0.68, 0.77)

0.910

(0.82, 1.01)

1.013

(0.80, 1.29)

  Multigenerational

0.722***

(0.67, 0.78)

0.815***

(0.73, 0.92)

1.532**

(1.15, 2.04)

  Skipped generation

0.775***

(0.68, 0.88)

0.729**

(0.60, 0.89)

1.607*

(1.04, 2.48)

  Adults and older adults

0.735***

(0.69, 0.78)

0.945

(0.86, 1.04)

1.269*

(1.00, 1.61)

 Age (in years)

1.000

(1.00, 1.00)

0.984***

(0.98, 0.99)

0.975***

(0.97, 0.98)

 Female (versus male)

1.019

(0.98, 1.06)

0.913**

(0.86, 0.98)

0.882

(0.75, 1.03)

 Race (versus White)

  Black

1.088*

(1.01, 1.17)

0.945

(0.84, 1.07)

0.929

(0.70, 1.24)

  Brown

1.091***

(1.04, 1.14)

0.925*

(0.86, 0.99)

1.138

(0.96, 1.35)

  Indigenous

1.493**

(1.13, 1.97)

1.813**

(1.21, 2.71)

1.895

(0.48, 7.55)

  Other

1.011

(0.81, 1.26)

0.921

(0.68, 1.25)

0.496

(0.22, 1.12)

 Education (versus no schooling)

  Less than high school

0.969

(0.91, 1.03)

1.082

(0.98, 1.20)

1.200

(0.97, 1.49)

  High school complete

0.892**

(0.83, 0.96)

1.579***

(1.40, 1.78)

1.942***

(1.47, 2.56)

  College or more

0.839***

(0.77, 0.92)

2.561***

(2.26, 2.90)

2.594***

(1.86, 3.61)

 Per capita household quartile (versus 1st)

  2

0.972

(0.92, 1.02)

1.029

(0.97, 1.09)

1.066

(0.94, 1.20)

  3

0.953

(0.90, 1.01)

1.174***

(1.10, 1.25)

1.255**

(1.09, 1.45)

  4

0.895***

(0.84, 0.96)

1.464***

(1.36, 1.57)

1.541***

(1.31, 1.82)

 Region (versus North)

  Northeast

0.893**

(0.83, 0.96)

0.819***

(0.73, 0.92)

0.345***

(0.24, 0.50)

  Southeast

0.781***

(0.73, 0.84)

0.435***

(0.39, 0.49)

0.112***

(0.08, 0.16)

  South

0.916*

(0.84, 0.99)

0.345***

(0.30, 0.39)

0.0778***

(0.05, 0.11)

  Center West

0.972

(0.89, 1.06)

0.948

(0.84, 1.07)

0.466***

(0.30, 0.72)

 Urban (versus rural)

1.016

(0.97, 1.07)

2.492***

(2.24, 2.77)

2.404***

(1.98, 2.92)

 Health conditions (versus none)

  Diabetes

1.236***

(1.18, 1.29)

1.227***

(1.15, 1.31)

1.538***

(1.33, 1.78)

  Hypertension

1.267***

(1.22, 1.32)

1.115***

(1.06, 1.17)

1.324***

(1.18, 1.48)

  Heart disease

1.494***

(1.42, 1.57)

1.330***

(1.24, 1.42)

1.253**

(1.06, 1.48)

  Asthma

1.998***

(1.89, 2.12)

1.552***

(1.44, 1.68)

1.495***

(1.22, 1.83)

  Cancer

1.364***

(1.25, 1.48)

1.228***

(1.10, 1.36)

1.284

(0.98, 1.69)

  Depression

1.771***

(1.67, 1.88)

1.237***

(1.14, 1.34)

1.468***

(1.20, 1.80)

 Proxy respondent (versus no)

0.608***

(0.58, 0.63)

0.934***

(0.90, 0.97)

1.024

(0.94, 1.12)

 Month (versus July)

  August

0.888***

(0.86, 0.92)

1.389***

(1.35, 1.43)

1.513***

(1.41, 1.62)

  September

0.735***

(0.71, 0.77)

1.739***

(1.69, 1.79)

1.949***

(1.82, 2.09)

  October

0.735***

(0.57, 0.63)

2.068***

(2.00, 2.14)

2.266***

(2.11, 2.43)

  November

0.599***

(0.58, 0.63)

2.331***

(2.26, 2.41)

2.496***

(2.32, 2.68)

 Constant

0.605***

(0.05, 0.07)

0.007***

(0.00, 0.01)

0.000***

(0.00, 0.00)

 Random ID

1.147

(1.10, 1.20)

6.783

(6.65, 6.92)

11.247

(10.83, 11.68)

  1. Source: Authors’ calculations using data from the COVID-19 PNAD, July–November. Robust standard errors have been estimated and account for the clustering of data on individuals
  2. Note: * p < 0.05, ** p < 0.01, *** p < 0.001, 95% CI: 95% confidence interval